🔴 Pharming Group is trading 7.3% down today on weak Q1 results and falling RUCONEST sales

Pharming Group is trading 7.3% down today at $13.02 as investors continue to react to weak Q1 2026 results and a sharp drop in RUCONEST sales.

• The company reported an 8% year-over-year revenue decline, with the stock remaining under significant pressure following its May earnings release.
• Investor sentiment remains cautious despite positive developments, including growth in Joenja and ongoing regulatory progress.
• The decline in core RUCONEST sales continues to weigh on the share price as the market focuses on the revenue miss.